1 |
MATSUMURA Y, STILES K M, REID J, et al. Gene therapy correction of Aldehyde Dehydrogenase 2 deficiency[J]. Molecular therapy. Methods & clinical development, 2019, 15: 72-82.
|
2 |
GOEDDE H W, AGARWAL D P, FRITZE G, et al. Distribution of ADH2 and ALDH2 genotypes in different populations[J]. Human genetics, 1992, 88(3): 344-346.
|
3 |
WANG W, WANG C, XU H, et al. Aldehyde dehydrogenase, liver disease and cancer[J]. International journal of biological sciences, 2020, 16(6): 921-934.
|
4 |
侯经远, 谢运泉, 赵平森, 等. 中国南方客家人群乙醛脱氢酶2基因多态性与急性心肌梗死的相关性研究[J]. 分子诊断与治疗杂志, 2019, 11(3): 170-175.
|
5 |
中华神经科学会, 中华神经外科学会. 各类脑血管疾病诊断要点(1995)[J]. 临床和实验医学杂志, 2013, 12(7): 559.
|
6 |
李志祥, 谢桂岚. ALDH2基因第12外显子(G/A)多态性在北京汉族人群的检测[J]. 中国现代医学杂志, 2005, 15(3): 457-458.
|
7 |
弭守玲, 范凡, 李纪明, 等. 乙醛脱氢酶2基因多态性在上海市与山东省汉族人群中的分布差异[J]. 中国临床医学, 2011, 18(6): 735-737.
|
8 |
谢钰珍, 覃鸿妮, 梅啸, 等. 江苏、山西、湖南三省份汉族人群ALDH2基因多态性分布研究[J]. 甘肃科技纵横, 2018, 47(10): 71-73.
|
9 |
王慧, 罗娥, 欧雅文. 广东地区汉族人群乙醛脱氢酶2基因Glu504Lys多态性的研究[J]. 检验医学与临床, 2018, 15(21): 3197-3199, 3202.
|
10 |
WU Y C, YAO Y, TAO L S, et al. The role of acetaldehyde dehydrogenase 2 in the pathogenesis of liver diseases[J]. Cellular signalling, 2023, 102: 110550.
|
11 |
罗云杰, 成守金. 人ALDH2基因多态性研究[J]. 检验医学与临床, 2020, 17(18): 2729-2732.
|
12 |
CHANG J S, HSIAO J R, CHEN C H. ALDH2 polymorphism and alcohol-related cancers in Asians: A public health perspective[J]. Journal of biomedical science, 2017, 24(1): 19.
|
13 |
曹西蓉, 吴德生. 汉族健康人201名的酒精代谢相关酶基因多态型分布[J]. 中华预防医学杂志, 2005, 39(2): 84-87.
|
14 |
徐筱婧, 瞿浩, 张华. 基因芯片法检测体检人群ALDH2基因多态性[J]. 国际检验医学杂志, 2016, 37(1): 11-12, 15.
|
15 |
ZHANG X, SUN A, GE J. Origin and spread of the ALDH2 Glu504Lys allele[J]. Phenomics, 2021, 1(5): 222-228.
|
16 |
LI W, YIN L, SUN X, et al. Alpha-lipoic acid protects against pressure overload-induced heart failure via ALDH2-dependent Nrf1-FUNDC1 signaling[J]. Cell death and disease, 2020, 11(7): 599.
|
17 |
SUN X, ZHU H, DONG Z, et al. Mitochondrial aldehyde dehydrogenase-2 deficiency compromises therapeutic effect of ALDH bright cell on peripheral ischemia[J]. Redox biology, 2017, 13: 196-206.
|
18 |
MONTEL R A, MUNOZ-ZULUAGA C, STILES K M, et al. Can gene therapy be used to prevent cancer? Gene therapy for aldehyde dehydrogenase 2 deficiency[J]. Cancer gene therapy, 2022, 29(7): 889-896.
|
19 |
徐斌, 罗晓, 张红, 等. ALDH2、ADH1B基因多态性在不同民族酒依赖者中的差异及其与饮酒行为的关系[J]. 中国药物依赖性杂志, 2021, 30(5): 358-364.
|
20 |
逄婷, 吴惠思, 邹茂贤, 等. 广州市番禺地区体检人群ALDH2基因的多态性分析[J]. 中国优生与遗传杂志, 2020, 28(3): 284-285, 298.
|
21 |
姜育燊, 姚利, 田刘敏, 等. 乙醛脱氢酶2基因多态性性别与地域分布研究[J]. 临床医学, 2019, 21(8): 1045-1046.
|
22 |
邱礼佳, 林贞葵, 陈慧怡, 等. 肇庆地区医学生ALDH2 rs671基因多态性的分布特征[J]. 检验医学与临床, 2022, 19(9): 1254-1257.
|
23 |
华德兴, 曾香连, 胡春梅, 等. 广东省韶关地区ALDH2基因调查及人群分布[J]. 海南医学, 2021, 32(20): 2623-2625.
|
24 |
帕丽达·阿布来提, 李辉, 刘莎莎, 等. 乙醛脱氢酶2基因多态性在冠心病患者传统危险因素之间的相关性研究[J]. 新疆医科大学学报, 2020, 43(10): 1273-1277.
|
25 |
边圆, 陈玉国, 徐峰, 等. 山东省汉族乙醛脱氢酶2基因多态性与急性心肌梗死的相关性[J]. 中国老年学杂志, 2010, 30(16): 2263-2265.
|
26 |
司英丽, 张冬青. 乙醛脱氢酶2基因多态性与急性脑梗死的相关性研究[J]. 检验医学与临床, 2023, 20(22): 3332-3335.
|
27 |
TAKAGI S, IWAI N, YAMAUCHI R, et al. Aldehyde dehydrogenase 2 gene is a risk factor for myocardial infarction in Japanese men[J]. Hypertension research: Official journal of the Japanese Society of Hypertension, 2002, 25(5): 677-681.
|
28 |
PAN C, ZHAO Y, BIAN Y, et al. Aldehyde dehydrogenase 2 Glu504Lys variant predicts a worse prognosis of acute coronary syndrome patients[J]. Journal of cellular and molecular medicine, 2018, 22(4): 2518-2522.
|
29 |
ZHU L P, YIN W L, PENG L, et al. Association of aldehyde dehydrogenase 2 Gene polymorphism with myocardial infarction[J]. Journal of inflammation research, 2021, 14: 3039-3047.
|
30 |
SUNG Y F, LU C C, LEE J T, et al. Homozygous ALDH2*2 is an independent risk factor for ischemic stroke in Taiwanese men[J]. Stroke, 2016, 47(9): 2174-2179.
|
31 |
吴和弟, 许丽娃, 吉家钗, 等. ALDH2基因多态性与海南地区汉族老年人群冠心病发病风险相关性[J]. 中国老年学杂志, 2022, 42(9): 2052-2055.
|